Wang Q, Zhou D, Shao D, Shen Z, Gu J
Gene Research Centre, Key Laboratory of Glycoconjugate, Ministry of Public Health, and Department of Biochemistry, Shanghai Medical University, Shanghai, People's Republic of China 200032.
Biochem J. 1997 Jun 1;324 ( Pt 2)(Pt 2):543-5. doi: 10.1042/bj3240543.
When quiescent rat hepatocellular carcinoma 7919 cells were treated with epidermal growth factor (EGF) or insulin (stimulators of receptor tyrosine kinase activity), the activity of N-acetylglucosaminyltransferase V was increased. The effect of EGF reached a maximum after 10 min and remained high for 30 min, while the effect of insulin reached a maximum after 5 min and decreased after 15 min. Preincubation of the cells with 1-O-octadecyl-2-O-methylglycerophosphocholine (Et18-OH3), which blocked the activation of mitogen-activated protein kinase by EGF, also blocked the activation of N-acetylglucosamyltransferase V by this hormone, whereas the activation of N-acetylglucosamyltransferase V by insulin could not be blocked by Et18-OH3. Our results suggest that N-acetylglucosamyltransferase V may be regulated by different receptor protein tyrosine kinase pathways.
当用表皮生长因子(EGF)或胰岛素(受体酪氨酸激酶活性刺激剂)处理静止的大鼠肝癌7919细胞时,N-乙酰葡糖胺基转移酶V的活性增加。EGF的作用在10分钟后达到最大值,并在30分钟内保持较高水平,而胰岛素的作用在5分钟后达到最大值,并在15分钟后下降。用1-O-十八烷基-2-O-甲基甘油磷酸胆碱(Et18-OH3)预孵育细胞,该物质可阻断EGF对丝裂原活化蛋白激酶的激活,也可阻断该激素对N-乙酰葡糖胺基转移酶V的激活,而Et18-OH3不能阻断胰岛素对N-乙酰葡糖胺基转移酶V的激活。我们的结果表明,N-乙酰葡糖胺基转移酶V可能受不同的受体蛋白酪氨酸激酶途径调控。